Literature DB >> 15019862

Preventing cardiovascular events in patients with diabetes mellitus.

William T Abraham1.   

Abstract

Diabetes mellitus and obesity are becoming increasingly prevalent in the United States. Patients with diabetes are 2 to 3 times more likely to develop cardiovascular disease (CVD) than are individuals without diabetes, but proper diabetes management and metabolic control can reduce this risk. Nonpharmacologic interventions, such as diet and exercise, can help to reduce weight and control insulin resistance, blood glucose levels, and lipid abnormalities, thereby lowering the risk of adverse cardiovascular outcomes. However, diet and exercise can provide particular challenges for the patient with diabetes. Antiobesity drugs, such as sibutramine and orlistat, can help individuals with diabetes lose weight and can have some effect on metabolic control. Alcohol use and hormone replacement therapy are still controversial topics with regard to reducing the risk of CVD. Smoking is known to be particularly dangerous for those with diabetes, and it is important for health care providers to help their patients stop smoking. Early and aggressive intervention in treating risk factors can reduce the risk of developing diabetes and prevent CVD in the patient with diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019862     DOI: 10.1016/j.amjmed.2003.10.019

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Current problems of food intake in young women in Japan: Their influence on female reproductive function.

Authors:  Tomoko Fujiwara; Rieko Nakata
Journal:  Reprod Med Biol       Date:  2004-08-10

2.  Phloroglucinol, a nutraceutical for IR-induced cardiac damage in diabetic rats.

Authors:  B Pranav Nayak; K R Ganesha; Nathani Minaz; Rema Razdan; Sumanta Kumar Goswami
Journal:  Animal Model Exp Med       Date:  2019-09-12

3.  Nurse-led motivational interviewing to change the lifestyle of patients with type 2 diabetes (MILD-project): protocol for a cluster, randomized, controlled trial on implementing lifestyle recommendations.

Authors:  Renate Jansink; Jozé Braspenning; Trudy van der Weijden; Louis Niessen; Glyn Elwyn; Richard Grol
Journal:  BMC Health Serv Res       Date:  2009-01-30       Impact factor: 2.655

4.  Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial.

Authors:  Adam Ali Ghotbi; Lars Køber; Nick Finer; W Philip T James; Arya M Sharma; Ian Caterson; Walmir Coutinho; Luc F Van Gaal; Christian Torp-Pedersen; Charlotte Andersson
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112

5.  Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes.

Authors:  Christopher Millett; Jeremy Gray; Sonia Saxena; Gopalakrishnan Netuveli; Azeem Majeed
Journal:  CMAJ       Date:  2007-06-05       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.